Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy

被引:0
作者
Ajam-Hosseini, Mobarakeh [1 ]
Babashah, Sadegh [1 ]
机构
[1] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, POB 14115-154, Tehran, Iran
关键词
Ferroptosis; MiRNA; Exosome; Molecular mechanism; Cancer therapy; CELL-DEATH; AUTOPHAGY; PROGRESSION; LYSOSOMES; PROTECTS; GROWTH; FORM;
D O I
10.1007/s11010-024-05169-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ferroptosis is a novel, iron-dependent form of non-apoptotic cell death characterized by the accumulation of lipid reactive oxygen species (ROS) and mitochondrial shrinkage. It is closely associated with the onset and progression of various diseases, especially cancer, at all stages, making it a key focus of research for developing therapeutic strategies. Numerous studies have explored the role of microRNAs (miRNAs) in regulating ferroptosis by modulating the expression of critical genes involved in iron metabolism and lipid peroxidation. Due to their diversity, unique properties, and dynamic expression patterns in diseases, exosomal miRNAs are emerging as promising biomarkers. Exosomes act as biological messengers, delivering miRNAs to target cells through specific internalization, thus influencing the ferroptosis response in recipient cells. This review summarizes the roles of miRNAs, with particular focus on exosomal miRNAs, in ferroptosis and their implications for cancer pathology. By examining the molecular mechanisms of miRNAs, we aim to provide valuable insights into potential therapeutic approaches.
引用
收藏
页码:3455 / 3476
页数:22
相关论文
共 160 条
  • [1] The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death
    Ai, Youwei
    Meng, Yutong
    Yan, Bo
    Zhou, Qinyi
    Wang, Xiaodong
    [J]. MOLECULAR CELL, 2024, 84 (01) : 170 - 179
  • [2] Nano based-oncolytic viruses for cancer therapy
    Ajam-Hosseini, Mobarakeh
    Akhoondi, Fatemeh
    Doroudian, Mohammad
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 185
  • [3] Autosis as a selective type of cell death
    Bai, Lingge
    Wu, Qiong
    Zhang, Xinyue
    Zhao, Yuting
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [4] MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4
    Bao, Chong
    Zhang, Jing
    Xian, Shu-Yue
    Chen, Feng
    [J]. FREE RADICAL RESEARCH, 2021, 55 (07) : 853 - 864
  • [5] Ferroptosis and Cancer: Mitochondria Meet the "Iron Maiden" Cell Death
    Battaglia, Anna Martina
    Chirillo, Roberta
    Aversa, Ilenia
    Sacco, Alessandro
    Costanzo, Francesco
    Biamonte, Flavia
    [J]. CELLS, 2020, 9 (06) : 1 - 26
  • [6] CircGFRA1 facilitates the malignant progression of HER-2-positive breast cancer via acting as a sponge of miR-1228 and enhancing AIFM2 expression
    Bazhabayi, Meiheban
    Qiu, Xingsheng
    Li, Xing
    Yang, Anli
    Wen, Wei
    Zhang, Xiaoli
    Xiao, Xiangsheng
    He, Rongfang
    Liu, Peng
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (21) : 10248 - 10256
  • [7] When cell death goes wrong: inflammatory outcomes of failed apoptosis and mitotic cell death
    Bock, Florian J.
    Riley, Joel S.
    [J]. CELL DEATH AND DIFFERENTIATION, 2023, 30 (02) : 293 - 303
  • [8] A FTH1 gene: pseudogene: microRNA network regulates tumorigenesis in prostate cancer
    Chan, Jia Jia
    Kwok, Zhi Hao
    Chew, Xiao Hong
    Zhang, Bin
    Liu, Chao
    Soong, Tuck Wah
    Yang, Henry
    Tay, Yvonne
    [J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (04) : 1998 - 2011
  • [9] The engineered exosomes targeting ferroptosis: A novel approach to reverse immune checkpoint inhibitors resistance
    Chen, Anqi
    Zhang, Wenjie
    Jiang, Chuwen
    Jiang, Zhengting
    Tang, Dong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (01) : 7 - 18
  • [10] Exosomal miR-223-3p from bone marrow mesenchymal stem cells targets HDAC2 to downregulate STAT3 phosphorylation to alleviate HBx-induced ferroptosis in podocytes
    Chen, Yueqi
    Yang, Xiaoqian
    Feng, Moxuan
    Yu, Yani
    Hu, Yongzheng
    Jiang, Wei
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15